| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | XENOPORT INC | 1,627,628 | 7,340,000 | 19.13% | ||
| 2 | LILLY ELI & CO | 65,400 | 4,709,000 | 12.28% | ||
| 3 | QUEST DIAGNOSTICS INC | 63,595 | 4,544,000 | 11.85% | ||
| 4 | AMICUS THERAPEUTICS INC | 333,513 | 2,818,000 | 7.35% | ||
| 5 | NEVRO CORP | 49,377 | 2,778,000 | 7.24% | ||
| 6 | NEUROCRINE BIOSCIE COM USD0.001 | 63,188 | 2,499,000 | 6.51% | ||
| 7 | UNITEDHEALTH GROUP INC | 17,900 | 2,307,000 | 6.01% | ||
| 8 | TEVA PHARMACEUTICAL INDS LTD | 41,286 | 2,209,000 | 5.76% | ||
| 9 | IMPAX LABORATORIES INC | 62,050 | 1,987,000 | 5.18% | ||
| 10 | AERIE PHARMACEUTICALS INC | 140,587 | 1,710,000 | 4.46% | ||
| 11 | BIO-RAD LABRATORIES | 12,050 | 1,647,000 | 4.29% | ||
| 12 | EDWARDS LIFESCIENCES CORP | 15,780 | 1,392,000 | 3.63% | ||
| 13 | CENTENE CORP DEL | 11,850 | 730,000 | 1.90% | ||
| 14 | QUIDEL CORP COM | 41,550 | 717,000 | 1.87% | ||
| 15 | ORASURE TECHNOLOGIES INC | 69,200 | 500,000 | 1.30% | ||
| 16 | Anacor Pharmaceuticals Inc | 8,850 | 473,000 | 1.23% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001657134-16-000005, filed 2016.04.21).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
